Home
Glenmark Pharmaceuticals Limited
Press Release Feb 17 2023
Business
Feb 17 2023
3 min read

Press Release Feb 17 2023

Glenmark Pharmaceuticals Limited has informed the Exchange regarding a press release dated February 17, 2023, titled "Glenmark Pharmaceuticals receives 2nd ANDA tentative approval for Saxagliptin Tablets, 2.5 mg and 5 mg".

View Attachment

Oorspronkelijke tekst
Deze vertaling beoordelen
Je feedback wordt gebruikt om Google Translate te verbeteren